The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results